Valuation Mega Lifesciences Thailand S.E.

Stocks

End-of-day quote Thailand S.E. 06/10/2026			5-day change	1st Jan Change
33.50 ^THB	0.00%		-2.90%	-

08-24	Mega Lifesciences Public Company Limited, Q2 2026 Earnings Call, Aug 14, 2026
08-13	Mega Lifesciences Public Company Limited Announces Declaration of Interim Dividend for Period from 01 January 2026 to 30 June 2026, Payable on 11 September 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	44,029	40,760	35,093	28,990	29,208	29,208	-	-
Change	-	-7.43%	-13.9%	-17.39%	0.75%	0%	-	-
Enterprise Value (EV) ¹	41,666	38,309	32,456	25,464	25,051	24,591	24,488	24,154
Change	-	-8.06%	-15.28%	-21.54%	-1.62%	-1.84%	-0.42%	-1.36%
P/E	22.6x	18.2x	17.6x	14.4x	15.3x	12.8x	11.7x	11x
PBR	5.5x	4.64x	3.77x	2.94x	2.86x	2.66x	2.64x	2.55x
PEG	-	1.2x	-1.6x	16.49x	-2.95x	0.7x	1.26x	1.65x
Capitalization / Revenue	3.08x	2.6x	2.24x	1.89x	2.06x	2.04x	1.88x	1.8x
EV / Revenue	2.91x	2.44x	2.07x	1.66x	1.77x	1.72x	1.58x	1.48x
EV / EBITDA	17.2x	13x	10.2x	6.78x	8.73x	7.76x	6.92x	6.41x
EV / EBIT	18.1x	14.3x	11.2x	7.56x	9.69x	8.77x	7.7x	7.14x
EV / FCF	16.2x	22.6x	19.6x	11.8x	11.9x	10.8x	12x	11.1x
FCF Yield	6.18%	4.42%	5.09%	8.46%	8.41%	9.29%	8.36%	9.03%
Dividend per Share ²	1.06	1.61	1.65	1.6	1.6	1.782	1.909	2.039
Rate of return	2.1%	3.44%	4.1%	4.81%	4.78%	5.32%	5.7%	6.09%
EPS ²	2.23	2.57	2.29	2.31	2.19	2.61	2.851	3.041
Distribution rate	47.5%	62.6%	72.1%	69.3%	73.1%	68.3%	66.9%	67%
Net sales ¹	14,301	15,686	15,681	15,344	14,147	14,330	15,499	16,271
EBITDA ¹	2,426	2,953	3,190	3,756	2,868	3,167	3,537	3,768
EBIT ¹	2,305	2,681	2,904	3,370	2,585	2,803	3,181	3,384
Net income ¹	1,947	2,242	1,993	2,012	1,912	2,243	2,486	2,652
Net Debt ¹	-2,363	-2,451	-2,636	-3,525	-4,156	-4,617	-4,720	-5,053
Reference price ²	50.50	46.75	40.25	33.25	33.50	33.50	33.50	33.50
Nbr of stocks (in thousands)	871,870	871,870	871,870	871,870	871,870	871,870	-	-
Announcement Date	23/02/22	25/02/23	22/02/24	24/02/25	24/02/26	-	-	-

¹THB in Million²THB

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.87x	11.93x	24.1x	0.6%	1,032B
JOHNSON & JOHNSON	28.34x	6.29x	17.98x	2.1%	614B
ABBVIE INC.	37.73x	7.89x	16.32x	2.6%	471B
MERCK & CO., INC.	103.26x	5.79x	24.59x	2.4%	350B
ROCHE HOLDING AG	19.01x	4.63x	11.48x	2.86%	337B
NOVARTIS AG	19.87x	5.19x	12.84x	3.07%	268B
ASTRAZENECA PLC	20.52x	4.22x	12.02x	2.1%	246B
AMGEN INC.	25.43x	6.65x	11.85x	2.51%	218B
GILEAD SCIENCES, INC.	-43.62x	6.37x	24.89x	2.28%	179B
Average	27.04x	6.55x	17.34x	2.28%	412.76B
Weighted average by Cap.	32.24x	7.67x	18.71x	1.95%